IBM (NYSE: IBM) announced today that it will sell healthcare data and analytics assets from its Watson Health business to Francisco Partners. Financial terms were not disclosed for the deal, expected to close in the second quarter of this year subject to customary regulatory clearances. But Bloomberg cites people familiar with the plans saying that […]
IBM Watson Health
IBM Watson to pull the plug on Merge Eye
UPDATED with a clarification from IBM Watson Health. Topcon Healthcare Solutions said today that it is a preferred vendor for IBM Watson Health Imaging in support of a transition plan for the Merge Eye imaging platform. IBM Watson plans to discontinue customer support for the Merge Eye Station digital fundus imaging platform and the Merge […]
Artificial intelligence and medicine: Is it overhyped?
Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver? AI could possibly fuel the future of medtech, enabling such thrilling innovations as implanted devices that instantly react to minute changes, software that can identify the best treatment options for individuals facing life-threatening conditions and fully-functioning autonomous surgical systems. […]
IBM Watson Health announces slew of AI-based research partnership deals
IBM Watson Health today announced a number of new partnership deals, including an expanded collaborative deal with the Broad Institute of MIT and Harvard and 10-year, $50 million collaborative research deals with the Brigham and Women’s Hospital and the Vanderbilt University Medical Center. The Cambridge, Mass.-based IBM division said that it inked an extended partnership with […]
Medtronic, IBM Watson debut hypoglycemia prediction feature for diabetes app
Medtronic (NYSE:MDT) and IBM Watson Health today launched a new feature for its Sugar.IQ personal diabetes assistant app that can predict the likelihood of a user experiencing a low glucose event within a four-hour window. The feature, called IQcast, uses AI tech from IBM and becomes more accurate as the low blood sugar event draws nearer, according to […]
Report: IBM Watson Health head DiSanzo steps down
International Business Machine‘s (NYSE:IBM) Watson Health GM Deborah DiSanzo is stepping away from her position heading the division to join the strategy team for IBM Cognitive Solutions, according to a STAT News report. Cognitive Solutions and IBM Research senior VP John Kelly will step in to take the reins of the healthcare-focused division, according to […]
IBM pushes back on negative Watson Health stories
IBM Watson Health (NYSE:IBM) is pushing back against reports that its artificial intelligence powered products deliver less than promised, claiming that the reports are unfair and ignore its capabilities. A number of news outlets, including The Wall Street Journal and STAT News, have recently published criticisms of IBM’s Watson Health offerings, claiming that its capabilities fall […]
Report: IBM Watson delivered ‘unsafe and inaccurate’ cancer recommendations
Internal documents from IBM Watson Health (NYSE:IBM) indicate that the company’s Watson for Oncology product often returns “multiple examples of unsafe and incorrect treatment recommendations,” according to a new report from STAT News. The documents come from slides presented last year by IBM Watson Health’s deputy chief health officer, according to the report, and include feedback […]
IBM Watson Health, VA extend precision oncology partnership deal
IBM Watson Health (NYSE:IBM) and the US Dept. of Veterans Affairs said today they extended their partnership using artificial intelligence to help interpret oncological data in the treatment of veteran patients. The partnership, originally signed between the two groups two years ago as part of the National Cancer Moonshot Initiative, will now be extended through to […]
Here are the top 5 medtech stories of mid-2018
A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read […]
Medtronic, IBM Watson Health launch AI-powered diabetes management app
Medtronic (NYSE:MDT), in partnership with IBM Watson Health, this week announced commercial availability of its AI-powered Sugar.IQ diabetes management app. Using artificial intelligence, the Sugar.IQ app evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines. Get the full story at our sister site, Drug Delivery Business […]
